Form D · Biotechnology
Mythic Therapeutics, Inc.
Waltham, MA · CIK 0001819730
Offering snapshot reported Dec 26, 2024 · SEC filing
- Reported sold
- $29.9M Offering amount: $30.4M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 9, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 26, 2024 | Initial | $29,868,794 | No comparison | 30 | SEC filing |
| Aug 14, 2020 | Initial | $4,749,262 | No comparison | 21 | SEC filing |
| Aug 14, 2020 | Initial | $18,849,989 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533328
Source: Form D, filed Dec 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Eliades | Director, Executive |
| Brian Fiske | Director, Executive |
| Jason Hanson | Director |
| Peter Hecht | Director |
| Josh Kopelman | Director |
| Alex Nichols | Director, Executive, Promoter |
| Sandra Poole | Executive |
| Bryan Roberts | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Beaver St., Ste 303
Waltham, MA, 02453
Waltham, MA, 02453